Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for high-risk chronic wet cough in children
ACTRN12623000098639Phase 4Recruiting
- Sponsor
- Queensland University of Technology
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 4, randomised, open-label trial of azithromycin in Protracted bacterial bronchitis (PBB) (2 arms), sponsored by Queensland University of Technology. Primary endpoint: Proportion of children with recurrent protracted bacterial bronchitis or bronchiectasis. Started Jul 2023; status: recruiting.
02
Drugs
azithromycin
03
Conditions
Protracted bacterial bronchitis (PBB)
Beyond the preview
Go deeper on ACTRN12623000098639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000098639.